| OVARY | 27 | OVARY FAILURE | 34 | White | After | No | No | Mucinous adenocarcinoma | 2011/3/10 | I | Under treatment | SG and CT | NA | 2012/10/1 | NA | 01/26/2012 | 18 |
| SARCOMA | 28 | Elegible | 78 | White | After | No | No | Splindle cell sarcoma | 2010/1/6 | I | Complete remission | SG and RT | NA | NA | NA | 01/26/2012 | 9.5 |
| BREAST | 29 | Elegible | 50 | White | After | No | No | Ductal carcinoma | 11/25/2009 | III | Complete remission | NA | NA | 05/27/2010 | NA | 01/26/2012 | 15.1 |
| BREAST | 30 | Elegible | 78 | White | After | No | No | Ductal carcinoma | 05/15/2010 | I | Complete remission | SG, RT and HT | NA | NA | NA | 01/27/2012 | 11.2 |
| BREAST | 31 | Elegible | 48 | White | After | No | No | Ductal carcinoma | 09/16/1963 | II | Under treatment | SG, RT and HT | NA | NA | NA | 01/27/2012 | 14.1 |
| BREAST | 32 | Elegible | 62 | White | After | No | No | Ductal carcinoma | 2010/1/6 | II | Complete remission | SG,RT and CT | NA | 2010/12/12 | NA | 01/27/2012 | 22.3 |
| GASTRO | 33 | Elegible | 84 | Pardo | After | No | No | Adenocarcinoma | 2007/5/4 | II | Complete remission | SG | NA | NA | NA | 01/27/2012 | 15.8 |
| GASTRO | 34 | Elegible | 69 | White | After | No | No | Adenocarcinoma | 01/28/2010 | II | Complete remission | SG | NA | NA | NA | 01/31/2012 | 6.1 |
| OVARY | 35 | Elegible | 59 | White | After | Yes | No | Serous adenocarcinoma | 1952/9/9 | IV | Under treatment | CT | 1 | 09/26/2012 | 3291.00 | 2012/1/1 | 3108.00 |
| OVARY | 36 | Elegible | 62 | White | After | Yes | No | Serous adenocarcinoma | 2009/1/11 | III | Under treatment | SG and CT | 2 | 2012/5/1 | 45.50 | 2012/2/2 | 38.80 |
| BREAST | 37 | Elegible | 61 | Pardo | After | No | No | Ductal carcinoma | 01/13/2009 | I | Complete remission | SG | NA | NA | NA | 2012/3/2 | 6.2 |
| BREAST | 38 | Elegible | 69 | Pardo | After | No | No | Ductal carcinoma | 2010/1/3 | II | Complete remission | SG,RT and HT | NA | NA | NA | 2012/3/2 | 14.3 |
| COLON | 39 | Elegible | 54 | Black | After | No | No | Adenocarcinoma | 2007/5/1 | III | Complete remission | SG and CT | NA | 2008/1/9 | NA | 2012/3/2 | 7.7 |
| ENDOMETRIUM | 40 | CONTROL FAILURE | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 2012/6/2 | 13.7 |
| OVARY | 41 | Elegible | 42 | White | After | Yes | No | Papillary adenocarcinoma | 08/25/2010 | III | Under treatment | SG and CT | 2 | 01/13/2012 | 77.20 | 2012/8/2 | 85.60 |
| OVARY | 42 | OVARY FAILURE | 36 | NA | After | No | No | Serous Boderline | 01/30/2011 | III | NA | SG | NA | NA | NA | 2012/8/2 | 10.6 |
| OVARY | 43 | Elegible | 63 | White | After | No | No | Serous adenocarcinoma | 11/21/2011 | III | NA | CT | 1 | 01/24/2012 | 248.00 | 2012/9/2 | 125.00 |
| OVARY | 44 | Elegible | 47 | White | After | Yes | No | Serous adenocarcinoma | 11/19/2010 | IV | Under treatment | SG and CT | 1 | 2011/4/4 | 79.00 | 2012/10/2 | 76.60 |
| OVARY | 45 | Elegible | 50 | White | After | Yes | No | Serous adenocarcinoma | 2009/1/7 | III | Under treatment | SG and CT | 2 | 09/30/2012 | 64.80 | 02/13/2012 | 68.30 |
| OVARY | 46 | Elegible | 57 | White | After | Yes | No | Serous adenocarcinoma | 2011/5/9 | III | Under treatment | SG and CT | 1 | 2012/7/2 | 329.00 | 02/27/2012 | 170.00 |
| OVARY | 47 | OVARY FAILURE | 71 | White | After | Yes | No | Adenocarcinoma | 2002/1/1 | III | Relapse | SG and CT | 2 | 2009/1/2 | 65 | 02/28/2012 | 34.9 |
| OVARY | 48 | Elegible | 50 | White | After | Yes | No | Serous adenocarcinoma | 2011/2/3 | III | Under treatment | SG and CT | 2 | 01/27/2012 | 15731.00 | 2012/1/3 | 20613.00 |
| OVARY | 49 | Elegible | 54 | White | After | Yes | No | Serous adenocarcinoma | 04/26/2011 | IV | Relapse | CT | NA | 2011/1/8 | 67.90 | 2012/6/3 | 85.00 |
| OVARY | 50 | Elegible | 58 | White | After | Yes | No | Adenocarcinoma | 01/20/2012 | IV | Under treatment | CT | 1 | 2012/1/3 | 2906.00 | 03/14/2012 | 2152.00 |
| OVARY | 52 | Elegible | 64 | White | After | No | No | Papillary adenocarcinoma | 2004/1/1 | I | Relapse and under treatment | NA | 3 | 01/27/2012 | 8200.00 | 03/15/2012 | 5790.00 |
| OVARY | 53 | Elegible | 56 | White | After | No | No | Adenocarcinoma | 02/21/2012 | IV | Under treatment | NA | NA | NA | 3640.00 | 03/21/2012 | 104.00 |
| OVARY | 54 | OVARY FAILURE | 71 | NA | After | No | No | Poorly differentiated carcinoma | 2011/1/10 | III | NA | NA | NA | 2012/5/3 | 221 | 03/21/2012 | 24.5 |
| BREAST | 55 | Elegible | 65 | Pardo | After | No | No | Invasive ductal carcinoma | 04/13/2011 | II | NA | SG, RT and CT | 1 | 11/29/2011 | NA | 03/27/2012 | 33 |